Competition to Collaboration
No-Strings Deals Let Rivals Combine Unapproved Drugs
By Trista Morrison
Monday, June 27, 2011
Science has taught us that many diseases including HIV, HCV and cancer can only be controlled by cocktails containing several drugs. Business has taught us that the best drugs don't necessarily come from your own pipeline, and they aren't always for sale. Hence the rise of no-money, no-rights, no-strings-attached deals to combine multiple unapproved drugs from multiple sponsors in a single clinical trial.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.